Lotus BioScience Ventures finances seed, early, and mid stage companies in the biotherapeutics industry.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 23, 2008
Humanigen
|
Series D | $20M | Biopharma | — |
Oct 19, 2005
Nereus Pharmaceuticals
|
Series D | $42.60M | Biotechnology | — |
Aug 11, 2005
Anadys Pharmaceuticals
|
Private Equity(PE) | $71.30M | Biotechnology | — |
Mar 16, 2005
Humanigen
|
Series B | $20M | Biopharma | — |
Jun 24, 2002
Infinity Pharmaceuticals
|
Series B | $70M | Biopharma | — |
Lotus BioScience Ventures has had 5 exits. Lotus BioScience Ventures most notable exits include Humanigen , Nereus Pharmaceuticals
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Aug 7, 2017 | Humanigen | IPO | Biopharma | Detail |
Jan 1, 2012 | Nereus Pharmaceuticals | M&A | Biotechnology | Detail |
Oct 17, 2011 | Anadys Pharmaceuticals | M&A | Biotechnology | Detail |
Aug 4, 2009 | Infinity Pharmaceuticals | IPO | Biopharma | Detail |
Feb 19, 2004 | Dynavax Technologies | IPO | Biopharma | Detail |